Merck and Moderna announced positive results from a large late-stage trial of their personalized mRNA cancer vaccine, which significantly reduced the recurrence of melanoma, the deadliest form of skin cancer..
Syndicated via official news feed
Syndicated feed content with full publisher credit.
Continue reading verified coverage and related developments on this desk.
Latest developments and reports from the desk
Nuevas exigencias de trazabilidad amenazan las exportaciones brasileñas de carne vacuna a Europa y ponen en riesgo un mercado de precios más altos. Nuevas exigencias de trazabilidad amenazan las exportaciones…
The yen strengthened sharply against the US currency, leaving traders on high alert for the potential that authorities may once again intervene in the foreign-exchange market.
Huge AI spending plans and the ongoing war in Iran are driving up borrowing costs around the world.